SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.
Equities
2196
CNE100001M79
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.66 HKD | +3.17% |
|
+3.33% | -19.65% |
| 01/07 | Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board and Board Committee Changes | CI |
| 28/06 | Shanghai Fosun Pharmaceutical Gets Registration Application Approval for Chest Pain Drug | MT |
ETFs positioned on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.37% | 4 M€ | -27.92% | ||
| 0.63% | 1 M€ | -23.69% | - | |
| 0.21% | 2 M€ | -0.97% | - | |
| 0.18% | 2 M€ | -14.14% | ||
| 0.16% | 4 M€ | -11.56% | ||
| 0.03% | 35 M€ | -5.85% | - | |
| 0.02% | 451 M€ | +9.66% | - | |
| 0.02% | 2,838 M€ | +12.38% | - | |
| 0.02% | 152 M€ | +9.71% | - | |
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 35 M€ | +6.43% | - | |
| 0.01% | 114 M€ | +7.19% | - | |
| 0.00% | 36 M€ | +10.53% | - | |
| 0.00% | 32 M€ | +5.00% | - | |
| 0.00% | 40 M€ | +7.31% | - | |
| 0.00% | 324 M€ | +8.53% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 17 M€ | +3.59% | - | |
| 0.00% | 15 M€ | +24.45% | ||
| 0.00% | 7 M€ | +5.07% | - | |
| 0.00% | 8 M€ | +0.41% | - |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities:
- research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;
- sale of medical equipments and diagnosis products (17.3%);
- medical and hospital services (10.5%);
- other (0.1%).
China accounts for 72.9% of net sales.
Sector
Pharmaceuticals
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
21.71
CNY
Average target price
28.61
CNY
Spread / Average Target
+31.77%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +54.07% | 81TCr | |
| +39.61% | 62TCr | |
| -7.05% | 35TCr | |
| +15.44% | 32TCr | |
| +5.72% | 29TCr | |
| +14.74% | 24TCr | |
| +0.61% | 22TCr | |
| +14.74% | 22TCr | |
| +7.42% | 17TCr |
- Stock Market
- Equities
- 600196 Stock
- 2196 Stock
- ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
